- Home
- CAN vs NRC Comparison
CAN vs NRC Comparison
Compare CAN & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CAN | NRC |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 427.9M | 390.8M |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | CAN | NRC |
|---|---|---|
| Price | $0.57 | $18.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $3.21 | N/A |
| AVG Volume (30 Days) | ★ 9.0M | 59.7K |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $63.64 | N/A |
| P/E Ratio | ★ N/A | $0.36 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $0.39 | $10.26 |
| 52 Week High | $2.22 | $22.79 |
Technical Indicators
Market Signals| Indicator | CAN | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 64.29 | 60.56 |
| Support Level | $0.43 | $17.85 |
| Resistance Level | $0.63 | $18.18 |
| Average True Range (ATR) | 0.03 | 0.71 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 89.71 | 75.41 |
Price Performance
Historical ComparisonAbout CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.